nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—IMPA1—mouth—cleft lip	0.0383	0.219	CbGeAlD
Lithium—IMPA1—telencephalon—cleft lip	0.0222	0.127	CbGeAlD
Lithium—GSK3B—embryo—cleft lip	0.0201	0.115	CbGeAlD
Lithium—GRIA3—telencephalon—cleft lip	0.0189	0.108	CbGeAlD
Lithium—GSK3B—telencephalon—cleft lip	0.0164	0.0936	CbGeAlD
Lithium—GSK3A—telencephalon—cleft lip	0.0142	0.0814	CbGeAlD
Lithium—IMPA1—head—cleft lip	0.0138	0.0792	CbGeAlD
Lithium—GRIA3—head—cleft lip	0.0118	0.0673	CbGeAlD
Lithium—GSK3B—head—cleft lip	0.0102	0.0583	CbGeAlD
Lithium—GSK3A—head—cleft lip	0.00886	0.0507	CbGeAlD
Lithium—GSK3A—B Cell Activation—FGFR3—cleft lip	0.000882	0.00107	CbGpPWpGaD
Lithium—GSK3B—PI-3K cascade—FGF2—cleft lip	0.000874	0.00106	CbGpPWpGaD
Lithium—GSK3A—Disease—WNT9B—cleft lip	0.000868	0.00105	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—FGFR2—cleft lip	0.000863	0.00105	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—FGFR2—cleft lip	0.000859	0.00104	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—FGFR1—cleft lip	0.000856	0.00104	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—FGFR2—cleft lip	0.000854	0.00104	CbGpPWpGaD
Lithium—GSK3B—Neural Crest Differentiation—FGF2—cleft lip	0.000853	0.00103	CbGpPWpGaD
Lithium—GSK3B—PI3K/AKT activation—FGF2—cleft lip	0.000853	0.00103	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—FGFR2—cleft lip	0.00085	0.00103	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FGF7—cleft lip	0.000848	0.00103	CbGpPWpGaD
Lithium—GSK3B—GAB1 signalosome—FGF2—cleft lip	0.000846	0.00103	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—FGF2—cleft lip	0.000846	0.00102	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—FGFR3—cleft lip	0.000845	0.00102	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.000844	0.00102	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—FGFR1—cleft lip	0.000842	0.00102	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—FGFR2—cleft lip	0.000838	0.00102	CbGpPWpGaD
Lithium—GSK3B—Notch Signaling Pathway—MYC—cleft lip	0.000835	0.00101	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—FGF2—cleft lip	0.000832	0.00101	CbGpPWpGaD
Lithium—GSK3B—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—cleft lip	0.000827	0.001	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—FGF3—cleft lip	0.000826	0.001	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ARHGAP29—cleft lip	0.00082	0.000994	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—FGF7—cleft lip	0.000815	0.000987	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—SUMO1—cleft lip	0.00081	0.000982	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—FGFR3—cleft lip	0.000809	0.00098	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—FGF9—cleft lip	0.000805	0.000976	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—FGFR1—cleft lip	0.000804	0.000975	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—FGFR1—cleft lip	0.0008	0.00097	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—FGFR2—cleft lip	0.0008	0.000969	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—FGFR2—cleft lip	0.0008	0.000969	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—FGFR2—cleft lip	0.0008	0.000969	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—FGFR1—cleft lip	0.000796	0.000965	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—TYMS—cleft lip	0.000796	0.000965	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—FGFR3—cleft lip	0.000796	0.000964	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—FGF2—cleft lip	0.000795	0.000963	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—FGFR2—cleft lip	0.000793	0.000961	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—FGFR1—cleft lip	0.000792	0.00096	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—FGF2—cleft lip	0.000791	0.000958	CbGpPWpGaD
Lithium—GSK3A—Immune System—IRF6—cleft lip	0.000788	0.000955	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—FGF2—cleft lip	0.000787	0.000954	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—FGFR2—cleft lip	0.000786	0.000952	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—FGF2—cleft lip	0.000783	0.000949	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FGF8—cleft lip	0.000783	0.000949	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—FGFR2—cleft lip	0.000782	0.000948	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—FGFR1—cleft lip	0.000781	0.000946	CbGpPWpGaD
Lithium—GSK3A—B Cell Receptor Signaling Pathway—MYC—cleft lip	0.000779	0.000944	CbGpPWpGaD
Lithium—GSK3B—Wnt Signaling Pathway—MYC—cleft lip	0.000774	0.000938	CbGpPWpGaD
Lithium—GSK3A—Disease—ABCA4—cleft lip	0.000774	0.000938	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—FGF2—cleft lip	0.000772	0.000935	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—FGFR3—cleft lip	0.00076	0.000921	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—FGFR3—cleft lip	0.000756	0.000917	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—FGFR3—cleft lip	0.000753	0.000912	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—FGF8—cleft lip	0.000752	0.000911	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—FGFR3—cleft lip	0.000749	0.000908	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—FGFR1—cleft lip	0.000746	0.000903	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—FGFR1—cleft lip	0.000746	0.000903	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—FGFR1—cleft lip	0.000746	0.000903	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—FGFR2—cleft lip	0.00074	0.000897	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—FGFR1—cleft lip	0.000739	0.000895	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—cleft lip	0.000738	0.000894	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—FGFR2—cleft lip	0.000737	0.000894	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.000737	0.000893	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—FGF2—cleft lip	0.000737	0.000893	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—FGF2—cleft lip	0.000737	0.000893	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—FGFR1—cleft lip	0.000732	0.000887	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—FGF2—cleft lip	0.00073	0.000885	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—FGFR1—cleft lip	0.000729	0.000884	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—FGF2—cleft lip	0.000724	0.000877	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—FGF2—cleft lip	0.000721	0.000873	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—FGFR2—cleft lip	0.000708	0.000858	CbGpPWpGaD
Lithium—GSK3A—Disease—SLC19A1—cleft lip	0.000708	0.000858	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—FGFR3—cleft lip	0.000705	0.000854	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—FGFR3—cleft lip	0.000705	0.000854	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—FGFR3—cleft lip	0.000705	0.000854	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—FGFR3—cleft lip	0.000698	0.000846	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000693	0.00084	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—FGFR3—cleft lip	0.000692	0.000839	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—FGFR1—cleft lip	0.00069	0.000836	CbGpPWpGaD
Lithium—GSK3A—Disease—WNT3—cleft lip	0.00069	0.000836	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—FGFR3—cleft lip	0.000689	0.000835	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—FGFR1—cleft lip	0.000687	0.000833	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—FGF2—cleft lip	0.000682	0.000826	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—FGF10—cleft lip	0.000679	0.000823	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	0.00066	0.0008	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—FGF2—cleft lip	0.000653	0.000791	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.000653	0.000791	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—FGFR3—cleft lip	0.000652	0.00079	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—FGFR3—cleft lip	0.00065	0.000787	CbGpPWpGaD
Lithium—GSK3B—Disease—WNT9B—cleft lip	0.000642	0.000778	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FGF3—cleft lip	0.000637	0.000772	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGF7—cleft lip	0.000627	0.00076	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—FGF2—cleft lip	0.000625	0.000757	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.000624	0.000756	CbGpPWpGaD
Lithium—IMPA2—Metabolism—TYMS—cleft lip	0.000622	0.000754	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FGF9—cleft lip	0.000621	0.000753	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—FGF2—cleft lip	0.000615	0.000745	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—FGF3—cleft lip	0.000612	0.000742	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—WNT9B—cleft lip	0.000608	0.000737	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGF7—cleft lip	0.000602	0.000729	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—FGF9—cleft lip	0.000597	0.000723	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—FGF2—cleft lip	0.000587	0.000712	CbGpPWpGaD
Lithium—GSK3A—Disease—TCN2—cleft lip	0.000587	0.000711	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—FGF2—cleft lip	0.000584	0.000708	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOG—cleft lip	0.000583	0.000706	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRF6—cleft lip	0.000582	0.000706	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—FGF2—cleft lip	0.000582	0.000705	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—FGF2—cleft lip	0.000579	0.000701	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGF8—cleft lip	0.000578	0.000701	CbGpPWpGaD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—MYC—cleft lip	0.000576	0.000698	CbGpPWpGaD
Lithium—GSK3B—Disease—ABCA4—cleft lip	0.000572	0.000693	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—FGF2—cleft lip	0.00057	0.000691	CbGpPWpGaD
Lithium—GSK3B—Neural Crest Differentiation—MYC—cleft lip	0.000558	0.000676	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGF8—cleft lip	0.000555	0.000673	CbGpPWpGaD
Lithium—IMPA1—Metabolism—TYMS—cleft lip	0.000554	0.000672	CbGpPWpGaD
Lithium—GSK3B—Wnt Signaling Pathway and Pluripotency—MYC—cleft lip	0.000553	0.00067	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—MYC—cleft lip	0.000547	0.000663	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—FGFR2—cleft lip	0.000545	0.00066	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—FGF2—cleft lip	0.000544	0.00066	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—FGF2—cleft lip	0.000544	0.00066	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.000544	0.00066	CbGpPWpGaD
Lithium—IMPA2—Metabolism—MTHFR—cleft lip	0.000543	0.000658	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ABCA4—cleft lip	0.000542	0.000657	CbGpPWpGaD
Lithium—GSK3A—Immune System—SUMO1—cleft lip	0.00054	0.000655	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—FGF2—cleft lip	0.00054	0.000654	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—FGF2—cleft lip	0.000535	0.000648	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—FGF2—cleft lip	0.000532	0.000645	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—MYC—cleft lip	0.000525	0.000636	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FGF10—cleft lip	0.000524	0.000635	CbGpPWpGaD
Lithium—GSK3B—Disease—SLC19A1—cleft lip	0.000523	0.000634	CbGpPWpGaD
Lithium—GSK3B—Disease—WNT3—cleft lip	0.00051	0.000618	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—FGFR1—cleft lip	0.000508	0.000615	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—FGF2—cleft lip	0.000504	0.000611	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—FGF10—cleft lip	0.000503	0.00061	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—FGF2—cleft lip	0.000502	0.000608	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF7—cleft lip	0.000494	0.000599	CbGpPWpGaD
Lithium—IMPA1—Metabolism—MTHFR—cleft lip	0.000484	0.000587	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—WNT3—cleft lip	0.000483	0.000585	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.000482	0.000584	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—FGFR3—cleft lip	0.00048	0.000582	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGF3—cleft lip	0.000471	0.000571	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—FGFR1—cleft lip	0.00046	0.000557	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGF9—cleft lip	0.000459	0.000556	CbGpPWpGaD
Lithium—GSK3A—Disease—SPRY2—cleft lip	0.000456	0.000553	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF7—cleft lip	0.000456	0.000553	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF8—cleft lip	0.000456	0.000553	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000453	0.000549	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGF3—cleft lip	0.000452	0.000548	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—WNT9B—cleft lip	0.000449	0.000545	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGF9—cleft lip	0.000441	0.000534	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—FGF10—cleft lip	0.000438	0.000531	CbGpPWpGaD
Lithium—GSK3B—Disease—TCN2—cleft lip	0.000433	0.000525	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOG—cleft lip	0.000431	0.000522	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF8—cleft lip	0.000421	0.00051	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FGFR2—cleft lip	0.000421	0.00051	CbGpPWpGaD
Lithium—GSK3A—Disease—MTR—cleft lip	0.000407	0.000493	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—FGFR2—cleft lip	0.000404	0.000489	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ABCA4—cleft lip	0.000401	0.000485	CbGpPWpGaD
Lithium—GSK3B—Immune System—SUMO1—cleft lip	0.000399	0.000484	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FGFR1—cleft lip	0.000392	0.000475	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGF10—cleft lip	0.000387	0.000469	CbGpPWpGaD
Lithium—IMPA2—Metabolism—NOS3—cleft lip	0.000379	0.000459	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—FGFR1—cleft lip	0.000376	0.000456	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGF10—cleft lip	0.000372	0.000451	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF3—cleft lip	0.000371	0.00045	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—FGF2—cleft lip	0.000371	0.000449	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FGFR3—cleft lip	0.00037	0.000449	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF7—cleft lip	0.000365	0.000442	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF9—cleft lip	0.000362	0.000439	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—WNT3—cleft lip	0.000357	0.000433	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—FGFR3—cleft lip	0.000356	0.000431	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF3—cleft lip	0.000343	0.000415	CbGpPWpGaD
Lithium—IMPA1—Metabolism—NOS3—cleft lip	0.000338	0.000409	CbGpPWpGaD
Lithium—GSK3B—Disease—SPRY2—cleft lip	0.000337	0.000408	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF7—cleft lip	0.000337	0.000408	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF8—cleft lip	0.000337	0.000408	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF9—cleft lip	0.000334	0.000405	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—FGFR1—cleft lip	0.000328	0.000397	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF7—cleft lip	0.000319	0.000387	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SPRY2—cleft lip	0.000319	0.000387	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF8—cleft lip	0.000311	0.000377	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGFR2—cleft lip	0.000311	0.000377	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF10—cleft lip	0.000305	0.00037	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—MYC—cleft lip	0.000301	0.000365	CbGpPWpGaD
Lithium—GSK3B—Disease—MTR—cleft lip	0.0003	0.000364	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGFR2—cleft lip	0.000298	0.000362	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF8—cleft lip	0.000295	0.000357	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—MYC—cleft lip	0.000292	0.000353	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGFR1—cleft lip	0.00029	0.000351	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FGF2—cleft lip	0.000286	0.000347	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF10—cleft lip	0.000282	0.000342	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGFR1—cleft lip	0.000278	0.000337	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—FGF2—cleft lip	0.000275	0.000333	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF3—cleft lip	0.000274	0.000332	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGFR3—cleft lip	0.000274	0.000332	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—MYC—cleft lip	0.000271	0.000328	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF9—cleft lip	0.000267	0.000324	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PTCH1—cleft lip	0.000265	0.000321	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGFR3—cleft lip	0.000263	0.000319	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF3—cleft lip	0.000253	0.000307	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF9—cleft lip	0.000247	0.000299	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGFR2—cleft lip	0.000245	0.000297	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF3—cleft lip	0.00024	0.000291	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—FGF2—cleft lip	0.00024	0.00029	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF7—cleft lip	0.000236	0.000286	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SPRY2—cleft lip	0.000236	0.000286	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF9—cleft lip	0.000234	0.000284	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGFR1—cleft lip	0.000228	0.000277	CbGpPWpGaD
Lithium—GSK3A—Disease—FGFR2—cleft lip	0.000226	0.000274	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF10—cleft lip	0.000226	0.000273	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—MYC—cleft lip	0.000223	0.000271	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF8—cleft lip	0.000218	0.000264	CbGpPWpGaD
Lithium—GSK3A—Disease—MTHFR—cleft lip	0.000218	0.000264	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGFR3—cleft lip	0.000216	0.000261	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGF2—cleft lip	0.000212	0.000256	CbGpPWpGaD
Lithium—GSK3A—Disease—FGFR1—cleft lip	0.000211	0.000255	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF10—cleft lip	0.000208	0.000252	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGF2—cleft lip	0.000203	0.000246	CbGpPWpGaD
Lithium—GSK3A—Disease—FGFR3—cleft lip	0.000199	0.000241	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF10—cleft lip	0.000197	0.000239	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTCH1—cleft lip	0.000196	0.000237	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGFR2—cleft lip	0.000181	0.000219	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF3—cleft lip	0.000177	0.000215	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF9—cleft lip	0.000173	0.00021	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGFR1—cleft lip	0.000169	0.000204	CbGpPWpGaD
Lithium—GSK3B—Disease—FGFR2—cleft lip	0.000167	0.000203	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF2—cleft lip	0.000167	0.000202	CbGpPWpGaD
Lithium—GSK3B—Disease—MTHFR—cleft lip	0.000161	0.000195	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGFR3—cleft lip	0.000159	0.000193	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGFR2—cleft lip	0.000158	0.000192	CbGpPWpGaD
Lithium—GSK3B—Disease—FGFR1—cleft lip	0.000156	0.000189	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF2—cleft lip	0.000154	0.000187	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS3—cleft lip	0.000152	0.000184	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGFR1—cleft lip	0.000148	0.000179	CbGpPWpGaD
Lithium—GSK3B—Disease—FGFR3—cleft lip	0.000147	0.000178	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF10—cleft lip	0.000146	0.000177	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGFR3—cleft lip	0.00014	0.000169	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF2—cleft lip	0.000123	0.000149	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGFR2—cleft lip	0.000117	0.000142	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF2—cleft lip	0.000114	0.000138	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS3—cleft lip	0.000112	0.000136	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGFR1—cleft lip	0.000109	0.000132	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF2—cleft lip	0.000108	0.000131	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOS3—cleft lip	0.000106	0.000129	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGFR3—cleft lip	0.000103	0.000125	CbGpPWpGaD
Lithium—GSK3A—Disease—MYC—cleft lip	0.000101	0.000122	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF2—cleft lip	7.97e-05	9.65e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOS3—cleft lip	7.86e-05	9.52e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MYC—cleft lip	7.44e-05	9.01e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MYC—cleft lip	7.05e-05	8.54e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MYC—cleft lip	5.21e-05	6.31e-05	CbGpPWpGaD
